The vaccinia virus D6R open reading frame encodes the small subunit of the heterodimeric vaccinia virus early transcription factor (VETF) that activates transcription of early genes in vitro. VETF binds early gene promoters and has a DNA-dependent ATPase activity that is essential for activation of transcription. To examine the relationship between the structure and function of VETF, we have localized the mutations in two temperature-sensitive viruses whose lesions previously were mapped to the D6R gene. For both mutants, a single G-to-A nucleotide change that would alter protein coding potential was identified. In mutant E93, the codon for alanine 25 was changed to that of threonine, and in mutant S4 the codon for valine 278 was replaced with that for methionine. The molecular phenotype of each mutant was assessed by expressing mutant transcription factors in HeLa cells by using a vaccinia virus-T7 system and characterizing the proteins' activities in vitro. The A25T mutant activated transcription to a lesser extent than wild-type VETF, and the V278M mutant had no demonstrable transcription factor activity. Both mutant proteins were shown to be defective for promoter binding, accounting for their impairment in transcription activation. The functional defects for both mutants were observed at permissive as well as nonpermissive temperatures. The mutant proteins retained ATPase activity but required higher DNA concentrations to activate the ATPase. These results indicate that the small subunit of VETF is essential for its promoter binding activity and likely contacts the promoter DNA. Immunoblotting experiments showed that the virion particles from the two mutant viruses contained about half the VETF of wild-type virus, suggesting that promoter binding may contribute to packaging of VETF into the virion particle. RNA polymerase, mRNA capping enzyme, and nucleoside triphosphate phosphohydrolase I were found at similarly reduced levels in the virion, indicating that packaging of some virion core enzymes may be interdependent.
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Vaccinia virus is a member of the poxvirus family, a family of large DNA viruses whose life cycle is restricted to the host cell cytoplasm (30) . The host cell nucleus apparently contributes few, if any, gene products that directly participate in the synthesis of viral nucleic acids. The self-reliance of the virus is possible because it encodes its own DNA polymerase and likely its accessory factors, a DNA-dependent RNA polymerase and its regulatory factors, and mRNA processing enzymes.
Vaccinia virus encodes approximately 200 different genes that are differentially activated at specific points of the viral life cycle. The timing of gene expression is controlled at the level of transcription initiation by class-specific factors that influence promoter choice by the RNA polymerase (31, 32) . About (23) . Among the products of the late genes are factors that are packaged into daughter virions for activation of early gene transcription in the subsequent round of infection.
Vaccinia virus early genes are transcribed by the RNA polymerase that is packaged within the virus core particle. A 94-kDa polypeptide associated with the RNA polymerase in submolar amounts is required for transcription of early genes (2, 22) . Early gene transcription by the viral RNA polymerase appears to require a single dissociable protein, the vaccinia virus early transcription factor (VETF) (12) . VETF binds specifically to early transcription promoters in the absence of the RNA polymerase (12, 19) , and thus appears to be the first step toward commitment to transcription of early genes. The VETF-promoter complex recruits the RNA polymerase to the site of initiation of RNA synthesis (25) . The transcription factor also has DNA-dependent ATPase activity (10) that has been shown to be essential for the activation of transcription (26) . ATP hydrolysis accelerates the dissociation of VETF from its promoter binding site, suggesting that ATP hydrolysis might be required for disengagement of the transcription initiation complex to allow elongation of the RNA chain (4) .
VETF is a heterodimeric protein encoded by the vaccinia virus D6R (5, 18) and A8L (18) (27) and inserted into the SmaI restriction endonuclease site in plasmid pUC118 (41) . Nested set deletions of the inserts were created with exonuclease III (20) , and single-stranded DNA was produced by using bacteriophage M13KO7 as a helper phage (41) . DNA sequences were determined by using Sequenase DNA polymerase (U.S. Biochemi Biochemical assays. Solution transcription assays were performed as described previously, using RNA polymerase purified from wild-type vaccinia virions (26) . The DNA template consisted of a synthetic early promoter directing transcription of a 400-nucleotide G-less cassette (26) . Recombinant 20 ,ug/ml.
Limited proteolysis of VETF was performed by adding freshly dissolved L-tosylamido-2-phenylethyl chloromethyl ketone-treated bovine trypsin (Sigma Chemical Co.) to a final concentration of 5 ,ug/ml at 31°C. At indicated times, samples were withdrawn and reactions were terminated by the addition of sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer and heated to 95°C for 10 min. Digestion products were analyzed by SDS-PAGE (12% polyacrylamide) and immunoblotting with antisera directed against recombinant VETF subunits (26).
Immunoblotting of virion particles. Vaccinia virions were purified by sucrose gradient centrifugation (21) . Approximately 0.2A260 units of virus were subjected to electrophoresis on an SDS-12.5% polyacrylamide gel and transferred to nitrocellulose for immunoblotting. Polypeptides were visualized by chemiluminescence with an ECL kit (Amersham) according to the manufacturer's recommendations. Proteins were quantitated by scanning densitometry of the X-ray films. Polyclonal antisera against vaccinia virus gene products D6R and A8L (VETF), E4L (RNA polymerase subunit), DilL (nucleoside triphosphate phosphohydrolase I), DiR and D12L (mRNA capping enzyme), and D8L (envelope surface antigen) were raised in rabbits against recombinant proteins expressed in bacteria (5) . Antibodies against the DiR, D8L, and D12L gene products were the generous gifts of E. G. Niles (State University of New York, Buffalo). Antiserum against the C-terminal 25 amino acids of the vaccinia virus BIR gene product (protein kinase) was provided generously by S. Lin (Purdue University).
Transcription reactions in isolated core particles. Transcription reactions were conducted in extracts of 0.05 A260
units of purified vaccinia virus as described previously (40) (33) . Mutant E93 had a nucleotide replacement of G with an A at nucleotide 73 of the open reading frame. This mutation changed codon 25 from alanine to threonine. Mutant S4 had a G-to-A replacement at nucleotide 832, changing codon 278 from valine to methionine. These mutations are consistent with a transition mutation expected from mutagenesis with Nmethyl-N-nitro-N-nitrosoguanidine and 5-bromouracil, which were used to generate the mutants (14, 17 (Fig. 1) . VETF was expressed in HeLa cells by using a vaccinia virus-T7 RNA polymerase system (26) .
VETF was expressed transiently from plasmid constructs bearing the vaccinia virus D6R and the A8L genes behind a bacteriophage T7 promoter. A six-histidine repeat was engineered onto the C terminus of the D6R gene product only to ensure that affinity-purified protein consisted exclusively of mutant VETF and not wild-type VETF encoded by the virus. VETF expressed by this method has transcription activator, promoter-binding, and DNA-dependent ATPase activities that are indistinguishable from those of native VETF (26) .
Site-directed mutagenesis was used to introduce nucleotide changes at nucleotide 73 or 832 found in the E93 and S4 D6R open reading frames, respectively, and the mutant proteins were coexpressed with the A8L gene product. Expression of recombinant protein was achieved by transfecting the two plasmids into cells that had been infected with a vaccinia virus expressing the T7 RNA polymerase (26) . Since the E93 and S4 viruses are temperature sensitive for growth, the mutant proteins were expressed at 31 and 37°C to determine whether synthesis of the mutants at elevated temperature affected their function. SDS-PAGE and immunoblotting of the affinitypurified proteins with antibodies directed against the D6R and A8L gene products demonstrated that both mutants were expressed at both temperatures; however, the yield of the purified VETF mutants was consistently about one-third that of wild-type VETF (data not shown). Protein yields were typically in the range of 10 to 50 p.g from 7 x 107 HeLa cells, and the protein was 30 to 50% pure with respect to the two VETF polypeptides as determined by SDS-PAGE and silver staining.
The coexpression and copurification of the mutant D6R and wild-type A8L gene products indicated that the mutant proteins retained the ability to dimerize. Expression of soluble A8L protein requires the coexpression of D6R polypeptide (24) . Only the mutant D6R polypeptides possessed the histidine tail required for binding to nickel-nitrilo-agarose. The presence of both polypeptides in the purified preparation demonstrates that they existed as a heterodimer.
Characterization of VETF mutants. Transcription assays were performed using a DNA template carrying a strong synthetic early promoter and purified RNA polymerase that is dependent on addition of VETF for activity. Transcription factor activity was tested with proteins expressed at 31 and 37°C. Assays were performed at 31 and 40°C to examine temperature sensitivity of the mutant proteins. Titration of the RNA polymerase with recombinant wild-type VETF showed the expected increase in transcription activity, peaking at a high concentration of the factor (Fig. 2) (Fig. 3) . When assayed at 31°C, the E93 mutant produced nearly equal amounts of the proteinpromoter complex as wild-type VETF under the standard assay conditions (Fig. 3) . This mutant was less active than the wild type when assayed for promoter binding at 40°C, producing significantly less of the factor-promoter complex. This was in contrast to that observed with the S4 mutant which produced a barely detectable protein-promoter complex whether assayed at 31 or 40°C. The affinity of the VETF mutants for the promoter was assessed in a more quantitative fashion by Scatchard analysis of binding. A fixed amount of protein was titrated with 32P-promoter DNA, and the fraction of the DNA bound to protein was determined. The promoter-binding activity of the S4 mutant was too low for a meaningful quantitation. At 31°C, the wild type had a Kd of 0.6 nM, and E93 had a Kd of 3.3 nM. At 40°C, the wild type and the E93 mutant had Kds of 1.3 and 9.7 nM, respectively. In summary, the affinity for promoter DNA for the E93 mutant relative to that of wild-type VETF was about fivefold lower at 31°C and sevenfold lower at 400C.
The two VETF mutants were analyzed for their ability to catalyze the DNA-dependent hydrolysis of ATP. Under conditions of high DNA concentrations that are optimal for activity, both mutants had ATPase activity that was comparable to or higher than that of wild-type VETF (Fig. 4) . Again, C J. VlIROL. the temperature used for the expression of the proteins did not markedly affect the proteins' activity. Since the wild-type and mutant VETFs vary in their affinity for promoter, the effect of DNA concentration on ATP hydrolysis was determined. ATPase assays were determined over a range of 1 ng to 10 ,ug in a 50-,ul reaction. At 31°C, wild-type VETF had half the maximal ATPase activity at about 34 ng and was optimal at about 100 ng per reaction (Fig. 5) . The activity of the E93 mutant was lower than that of wild-type activity at low DNA concentrations but exceeded that of the wild type above 100 ng. Much higher DNA concentrations were required to observe ATPase activity with the S4 mutant. With 10 p.g of DNA, the activity of the S4 mutant also exceeded that of the wild-type VETF. Virtually identical results were obtained with proteins assayed at 40°C. The mutant VETFs required higher DNA concentrations than wild-type VETF for stimulation of the ATPase activity, but the mutant VETFs had higher activity than the wild type at very high DNA concentrations.
Mutations impairing protein function may replace amino acids directly participating in the protein's function or, alternatively, can disrupt secondary and/or tertiary structure necessary for activity. In an attempt to determine which of these possibilities was responsible for the phenotypes of the E93 and S4 mutants, the proteins were subjected to limited proteolysis with trypsin as a probe of structure. The accessibility of trypsin cleavage sites gives an indication of the exposure of these sites to the solvent. The cleavage of the proteins was followed as a function of time, and cleavage products were analyzed by immunoblotting with antibodies directed against the D6R or A8L gene products. Digestion of wild-type VETF resulted in the gradual disappearance of the full-length 70-kDa D6R gene product and the rapid appearance of new major polypeptides of 48, 41, 29.5, and 20.5 kDa (Fig. 6) the wild type, and polypeptides of 35 and 27 kDa were observed with the S4 protein that were not present in digests of wild-type VETF. Immunoblotting of tryptic digests by using antibody directed against the C-terminal 260 amino acids of the small subunit of VETF detected all of the polypeptides described above except the 27-kDa polypeptide in digests of S4 protein and the 20.5-kDa protein seen in wild-type and S4 protein (data not shown). Thus, the V278M mutation affected the trypsin cleavage pattern in both halves of the D6R polypeptide. These results indicate that the structure of the S4 small subunit was significantly altered relative to that wild-type VETF.
The structure of the large subunit of VETF was also analyzed for trypsin sensitivity by immunoblotting with antibodies against the A8L gene product. Trypsin produced multiple cleavage products in the wild type, S4 mutant, and E93 mutant; however, no significant differences in the three proteins were noted.
Protein composition of mutant virions. As described above, the E93 and S4 mutants of VETF had reduced affinity for promoter DNA. It is reasonable to suggest that promoter binding may be the mechanism responsible for packaging of VETF into the virus core particle. It therefore follows that the levels of VETF in the core of the two mutants may be reduced as a result of lower affinity for promoter DNA. This notion was tested by immunoblot analysis of purified vaccinia virions. The virions of the E93 and S4 mutants were found to contain reduced amounts of the D6R and A8L gene products relative to the wild-type virus (Fig. 7) . Mutant virions contained about one-third to one-half the VETF of wild-type virions (Table 1) . For comparison, the virions also were analyzed for the presence of several other virion-associated proteins. The D8L gene product, a component of the virus envelope (35) , was present in the virions of mutants E93 and S4 in quantities similar to that of wild-type virus. Also, the protein kinase that is encoded by the B1R gene (3, 27, 36) was present in both mutant virions at quantities similar to or higher than those in the wild type. The levels of the mRNA capping enzyme (encoded by the DiR and D12L genes) (29, 34) , nucleoside triphosphate phosphohydrolase I (NPH I) (encoded by the Dl1L gene) (9, 37) , and an RNA polymerase subunit (encoded by the E4L gene) (1, 11) were found in the virions of the two mutants at lower levels than that in wild-type virions. Quantitation of the immunoblots by densitometry revealed that these polypeptides that were reduced relative to their wild-type counterparts were present at about one-third to one-half the wild-type levels (Table 1) . Transcription activity of mutant virus core particles. The virions from mutants E93 and S4 had reduced levels of VETF, RNA polymerase, and other enzymes that may affect the efficiency of transcription of vaccinia virus early genes. The effect of the VETF mutations on transcription in the core environment was determined with core particles permeabilized by detergent extraction of purified virions. The 32P-labeled RNA was fractionated by differential centrifugation into that released from the cores and that which remained bound to cores. At 31°C, RNA synthesized and released from the cores of the E93 and S4 mutants was less than half the RNA produced by wild-type core particles (Fig. 8) . Similar results were obtained at 40°C, except the transcription activity of S4 cores was almost completely inactive. These findings are in agreement with a previous report from Christen et al. (13) . Quantitation of RNA that remained associated with core particles after transcription revealed that wild-type core particles retained approximately 25 to 30% of the RNA, whereas the two mutant cores retained about 50% of the total RNA synthesized. The mutant core particles released a substantially lower fraction of the total RNA produced in the transcription reactions.
DISCUSSION
The mutations responsible for the temperature-sensitive phenotype of two vaccinia virus mutants were identified in the D6R gene. Mutant E93 had a mutation resulting in threonine being substituted for alanine 25, and mutant S4 had methionine substituted for valine 278. Mutant versions of these proteins were expressed along with the large subunit of VETF, and analysis of function in vitro demonstrated that the S4 VETF mutant had no detectable ability to activate transcription by the RNA polymerase. The E93 VETF mutant exhibited about half the transcription factor activity as wild-type VETF. Analysis of promoter binding activity showed that this was the Purified virions from each of the two mutant viruses was found to contain reduced amounts of VETF. This in agreement with a previous study (13) . This result is expected if promoter DNA binding is the basis for recruitment of VETF for packaging into the virion core structure. DNA binding may not be the sole factor contributing to the packaging of VETF into virions since there was not a good correlation between the efficiency of promoter DNA binding by the mutant proteins and the levels of VETF found in mutant virions. Both mutant viruses were found to contain similar levels of VETF; however, the two mutant transcription factors exhibited a very large difference in affinity for promoter DNA. It is possible that VETF is packaged into the virion core structure by means of DNA binding, but other proteins may stabilize the interaction of the mutant proteins within the core structure.
In addition to VETF, several other core-associated enzymes were found in the mutant virus particles at similarly reduced levels relative to that of wild-type virus. RNA one-third the amounts found in wild-type virions. It seems highly unlikely that two independently isolated mutant viruses would exhibit this same property unless they shared a common defect. The observed effects on protein packaging did not extend to all virion components. The protein kinase encoded by the viral BlR gene and an envelope-associated protein encoded by the D8L gene were not reduced in the mutant virions compared with wild-type virus. The RNA polymerase synthesizes the RNA chain, and the mRNA capping enzyme function in transcription termination (39) . The role of NPH I in transcription is unknown; however, a recent report provided evidence that it is required for early and late mRNA synthesis (16) . All three proteins found to be reduced in mutant virions function in mRNA synthesis. A previous study showed that the RNA polymerase, mRNA capping enzyme, NPH I, and VETF (as implied by transcription activity of the complex) existed in a high-molecular-weight complex upon extraction of virus particles with detergent (8) . It is possible that the vaccinia virus early gene transcription apparatus may be assembled into virion cores by complexing with VETF that is anchored at transcription promoters via its site-specific DNA binding activity. This model is attractive because it explains how a complicated apparatus with multiple components could be packaged into particles with nearly equal stoichiometry of the components. Proof of this model will require additional study. 
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